Acetazolamide and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetazolamide (acetazolamide) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include ear infection among females and burkholderia test positive among males.

The phase IV clinical study analyzes what interactions people have when they take Acetazolamide and Solu-cortef. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

On Jul, 10, 2026

21 people who take Acetazolamide and Solu-cortef together, and have interactions are studied.

Acetazolamide and Solu-cortef drug interactions.

What are the common drug interactions of Acetazolamide and Solu-Cortef, by gender? *:

female:

Ear infection
Sinusitis (inflammation of sinus)
Migraine (headache)
Nephrolithiasis (calculi in the kidneys)
Urinary tract infection
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Breast cancer
Dry eye (lack of adequate tears)
Gastric dysplasia (stomach with abnormality of development)
Gastritis (inflammation of stomach)

male:

Burkholderia test positive
Hepatic enzyme increased
Syncope (loss of consciousness with an inability to maintain postural tone)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Ventricular dysfunction (heart dysfunction)
Ventricular failure (heart failure)
Asthenia (weakness)
Dizziness
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cardiac failure

What are the common drug interactions of Acetazolamide and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Agitation (state of anxiety or nervous excitement)
Cardiac arrest
Collapse (sudden functional breakdown)
Confusion
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Headache (pain in head)
Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)

30-39:

n/a

40-49:

Death
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Sinusitis (inflammation of sinus)
Toxic skin eruption (skin breakdown due to toxic substance)
Upper respiratory tract infection
Hepatic enzyme increased
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Blood alkaline phosphatase increased
Ear infection

50-59:

n/a

60+:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cystitis haemorrhagic (blood in the urine and painful voiding)
Hypoxia (low oxygen in tissues)
Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
Pneumonia influenzal (the flu with pneumonia)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 28.57%
Primary Immunodeficiency Syndrome: 5 people, 23.81%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 3 people, 14.29%
Hereditary Angioedema (recurrent episodes of severe swelling): 3 people, 14.29%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 3 people, 14.29%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously